PIIINP and ST2/IL-33R, biomarkers of liver fibrosis, were elevated only in the NAFLD/NASH and ALD patients, suggesting that both biomarkers detect fibrosis and late-stage liver disease. This evidence concerns the gene IL1RL1 and metabolic dysfunction-associated steatotic liver disease.